Literature DB >> 7779468

General practitioners' tacit and stated policies in the prescription of lipid lowering agents.

J S Evans1, C Harries, I Dennis, J Dean.   

Abstract

BACKGROUND: Research into general practitioners' prescribing behaviour with regard to lipid lowering agents has relied on survey methods which presume that doctors have insight into their prescribing behaviour and can describe it accurately. AIM: This study set out to measure the tacit policies used by general practitioners in prescribing lipid lowering agents and to compare these with their stated policies.
METHOD: Effects of 13 separate cues on decisions to prescribe were examined. The cues included cholesterol levels and a number of associated risk factors for coronary heart disease. Doctors rated 130 imaginary cases presented by a computer. Thirty five general practitioners in the Plymouth area participated in the study. Their ages ranged from 31 to 55 years and all but four were men. The raw data in each case was a rating of the likelihood that the doctor would prescribe for the patient described. These were converted into statistical weightings by use of multiple linear regression. The pattern of (standardized) weights constituted the tacit policy for each doctor. Stated policies were measured in a subsequent interview by asking doctors to rate the influence of each cue.
RESULTS: Both tacit and stated policies diverged widely between different doctors. Most doctors overestimated the number of cues that had actually influenced their decisions, and many believed that they had taken into account associated factors for coronary heart disease when they had not. On lifestyle related risks doctors were generally less likely to treat overweight people and most stated this as their policy. Most were also less likely to treat smokers but some had the opposite policy. Those less likely to treat smokers were also less likely to treat obese patients. There was also considerable variation in the extent to which the doctors took account of the attitude of the patient to receiving treatment.
CONCLUSION: Doctors' policies are highly variable and particularly inconsistent in the treatment of smokers. Relevant risk factors may be ignored--even though they are understood--because the risk assessment involved is too psychologically complex a task to be performed intuitively. Decision aids and clear protocols are needed in this area.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779468      PMCID: PMC1239107     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  7 in total

1.  Inability of rheumatologists to describe their true policies for assessing rheumatoid arthritis.

Authors:  J R Kirwan; D M Chaput de Saintonge; C R Joyce; J Holmes; H L Currey
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

2.  Clinical judgment in rheumatoid arthritis. II. Judging 'current disease activity' in clinical practice.

Authors:  J R Kirwan; D M Chaput de Saintonge; C R Joyce; H L Currey
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

3.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

4.  Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.

Authors:  M R Law; N J Wald; T Wu; A Hackshaw; A Bailey
Journal:  BMJ       Date:  1994-02-05

5.  Assessing possible hazards of reducing serum cholesterol.

Authors:  M R Law; S G Thompson; N J Wald
Journal:  BMJ       Date:  1994-02-05

6.  Medical students' and residents' estimates of cardiac risk.

Authors:  T G Tape; R S Wigton
Journal:  Med Decis Making       Date:  1989 Jul-Sep       Impact factor: 2.583

7.  The cholesterol papers.

Authors:  M Marmot
Journal:  BMJ       Date:  1994-02-05
  7 in total
  14 in total

1.  Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

Authors:  D M Pickin; C J McCabe; L E Ramsay; N Payne; I U Haq; W W Yeo; P R Jackson
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.

Authors:  John Kedward; Lorraine Dakin
Journal:  Br J Gen Pract       Date:  2003-09       Impact factor: 5.386

Review 3.  The role of computerized decision support in reducing errors in selecting medicines for prescription: narrative review.

Authors:  Melissa T Baysari; Johanna Westbrook; Jeffrey Braithwaite; Richard O Day
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

4.  Impact of obesity on resource utilization for general surgical procedures.

Authors:  Mary T Hawn; John Bian; Ruth R Leeth; Gilbert Ritchie; Nechol Allen; Kirby I Bland; Selwyn M Vickers
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

5.  Which doctors are influenced by a patient's age? A multi-method study of angina treatment in general practice, cardiology and gerontology.

Authors:  Clare Harries; Damien Forrest; Nigel Harvey; Alastair McClelland; Ann Bowling
Journal:  Qual Saf Health Care       Date:  2007-02

6.  A general practice-based study examining the absolute risk of cardiovascular disease in treated hypertensive patients.

Authors:  T P Fahey; T J Peters
Journal:  Br J Gen Pract       Date:  1996-11       Impact factor: 5.386

7.  Evaluation of nurses' self-insight into their pain assessment and treatment decisions.

Authors:  Adam T Hirsh; Mark P Jensen; Michael E Robinson
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

8.  What constitutes controlled hypertension? Patient based comparison of hypertension guidelines.

Authors:  T P Fahey; T J Peters
Journal:  BMJ       Date:  1996-07-13

9.  Statin a day keeps cancer at bay.

Authors:  Siddharth Singh; Preet Paul Singh
Journal:  World J Clin Oncol       Date:  2013-05-10

10.  GPs' decisions on drug treatment for patients with high cholesterol values: a think-aloud study.

Authors:  Lars Backlund; Ylva Skånér; Henry Montgomery; Johan Bring; Lars-Erik Strender
Journal:  BMC Med Inform Decis Mak       Date:  2004-12-13       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.